GAO’s reports and testimonies give Congress, federal agencies, and the public timely, fact-based, non-partisan information that can improve government operations and save taxpayers billions of dollars.
Remdesivir was the first drug approved by the Food and Drug Administration to treat COVID-19. Gilead Sciences, Inc., originally developed it to treat other viral diseases.
We reviewed federal contributions to development of remdesivir and related agency patent rights.
As of Dec.
This report updates our oversight of federal actions to support public health, individuals, and the economy during the COVID-19 pandemic. Findings include:
There have been shortages of personal protective equipment and testing supplies because very few of them are made in the U.S.